Kevin W. Quinn, Dmd, P.c. Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 74 Faunce Corner Rd, Suite 620, N Dartmouth, MA 02747 Phone: 508-997-2999 Fax: 508-997-5099 |
Hawthorn Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 530 Hawthorn St, N Dartmouth, MA 02747 Phone: 508-994-5443 |
Yujin Lee, Dmd, P.c. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 424 State Rd, N Dartmouth, MA 02747 Phone: 508-557-8240 |
Alpha Dental Center Of Dartmouth, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 145 Faunce Corner Rd Ste C, N Dartmouth, MA 02747 Phone: 508-993-5900 Fax: 508-993-5912 |
Mark S Grenier Dmd Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 78 Faunce Corner Rd, Suite 535, N Dartmouth, MA 02747 Phone: 508-992-4243 Fax: 508-992-4250 |
News Archive
A child who suffers a moderate or severe traumatic brain injury (TBI) may still have substantial functional disabilities and reduced quality of life 2 years after the injury. After those first 2 years, further improvement may be minimal. Better interventions are needed to prevent long-lasting consequences of TBI in children conclude the authors of a study published in Journal of Neurotrauma, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
iBio, Inc., its development collaborator, Fraunhofer USA Center for Molecular Biotechnology (CMB), and GE Healthcare, a unit of General Electric Company, today announced their entry into an agreement to jointly develop and globally market manufacturing solutions for biopharmaceuticals and vaccines based upon their respective proprietary technologies.
Nfocus Neuromedical, Inc., an innovative medical device company with a focus on the next generation treatment for brain aneurysms, announced today that its Luna Aneurysm Embolization System received CE Mark for the treatment of patients with brain aneurysms.
Ipsen today announced the preliminary results of a phase I trial in metastatic breast cancer with BN83495, Ipsen's lead and first-in-class orally available irreversible steroid sulfatase (STS) inhibitor.
› Verified 8 days ago